TL;DR
Get oils, diffusers and self-care delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Craig Hockenberry’s Oct. 28 post describes his experience with lymphoma treatment, including chemotherapy side effects, a pneumonia infection and nerve damage. He reports that his strength and stamina began returning after his final infusions in May and that he later noticed signs he believed indicated nerve recovery; the report does not establish his current medical status or treatment outcome.
Craig Hockenberry published a personal health update on Oct. 28 describing his experience with lymphoma treatment, including chemotherapy side effects, a serious pneumonia infection and nerve damage that affected his walking and balance. He says his strength and stamina began to return after his final infusions in May, and he later experienced a sensation he interpreted as a possible sign of nerve recovery; the post does not specify his current medical status or confirm the treatment outcome.
In the account published on Furbo.org, Hockenberry describes first receiving weekly lumbar punctures over a six-week period that ended in January. He says doctors removed spinal fluid for analysis and replaced it with methotrexate. He experienced severe headaches afterward and spent many days lying flat, which he said eased the pressure. The post does not provide a diagnosis date or detailed clinical records.
Hockenberry says he then received chemotherapy infusions of bendamustine and rituximab on a 28-day cycle. He reports changes to his taste, fatigue, loss of muscle mass and a 50-pound weight loss over a couple of months. He says he avoided nausea and hair loss, though his hair lost its usual thickness and curl. These are his descriptions of his personal experience, not a guide to what other patients should expect.
He also recounts a pneumonia infection in March, after an infusion, that he says affected him while his immune system was weakened. According to his post, his blood oxygen fell below 90%, and his Apple Watch alerted him to an episode of atrial fibrillation. He says antibiotics quickly treated the pneumonia. His doctor offered to skip the next chemotherapy cycle, but Hockenberry says he chose to continue.
Treatment’s Effects on Daily Mobility
The account shows how a cancer treatment experience can involve more than the infusion itself. Hockenberry describes fatigue, weight loss and altered taste, alongside an infection and ongoing nerve symptoms that made everyday activities, including walking and using stairs, difficult. His account offers readers a first-person description of how those effects changed over time, while not establishing how another patient might respond.
His description of gradual recovery also underscores the uncertainty he faced about his mobility. After the final infusions in May, he says walks became longer and his strength and stamina returned. He then noticed a new sensation in the backs of his legs when he bent his head forward, which he took as evidence that his nerves might be recovering. That interpretation is personal: the post does not include a clinician’s assessment confirming the cause or extent of any nerve repair.
Products Worth Considering
Bowflex SelectTech 840 Adjustable Kettlebell
Therabody JetBoots Prime Wireless Compression Boots – Short (under 29 inseam)
Philips Sonicare 5950 Rechargeable Electric Toothbrush with 2 Brush Heads, Pink
As an affiliate, we earn on qualifying purchases.
From Spinal Treatment to Infusions
Hockenberry’s post traces several stages of treatment rather than reporting a new clinical finding or a change in public health guidance. He says the weekly lumbar punctures ended in January, followed by chemotherapy infusions on a 28-day schedule. The final infusions took place in May, after which he describes a slow return of appetite, strength and walking distance.
Before describing the treatment, he mentions that nerve damage had already affected his gait and balance and was not improving during the infusions. He says tingling and numbness became a growing concern. The source does not explain when the nerve damage began, identify its medical cause, or provide details about the lymphoma type, stage or broader treatment plan.
Hockenberry also writes about taking daily walks despite fatigue and balance problems, using walking sticks his wife found. He presents walking as part of his own routine, not as medical advice. His post emphasizes that symptoms and treatment experiences differed from what he had expected, including his own experience of avoiding some commonly discussed digestive effects.
“I’m writing this post from a hospital bed. And I couldn’t be happier.”
— Craig Hockenberry, in his Oct. 28 post on Furbo.org
Current Condition Still Unspecified
The post does not state why Hockenberry was in a hospital bed when he wrote, whether he remains hospitalized, or what his current health status is. It also does not report follow-up scans, test results, whether the lymphoma is in remission, or whether additional treatment is planned.
His account says a sensation in his legs appeared to signal nerve recovery, but it does not identify a confirmed diagnosis of the nerve problem or include a medical evaluation establishing that the nerves were repairing. The cause of the earlier nerve damage and its lasting effects remain unclear from the material provided. The reported oxygen reading and atrial fibrillation alert are also not accompanied by clinical records or further details about follow-up care.
Follow-Up Details to Watch
Hockenberry’s post does not announce a specific upcoming treatment, appointment or publication date. The next information readers would need to understand his status would be a direct update from him or details he chooses to share about follow-up care, nerve symptoms and lymphoma treatment. Until then, the account should be read as a personal description of events through the period after his final May infusions, not as a current clinical report.
Any further assessment of his recovery would depend on information from Hockenberry or his care team. The post itself does not say whether the leg sensations continued, whether his mobility fully recovered, or whether his doctors confirmed an improvement in nerve function.
Key Questions
Who published the health update?
Craig Hockenberry published the personal account on Furbo.org on Oct. 28, 2026.
What treatment does Hockenberry describe?
He describes a six-week course of weekly lumbar punctures involving methotrexate, followed by 28-day-cycle infusions of bendamustine and rituximab. His post says his final infusions were in May.
What complications did he report?
Hockenberry reports severe headaches after lumbar punctures, fatigue, altered taste, muscle loss, substantial weight loss, nerve-related mobility problems and a pneumonia infection in March. These details reflect his own account.
Does the post confirm that his nerves recovered?
No. He says he felt a new sensation in his legs that he believed signaled nerve recovery, but the post does not include a clinician’s confirmation or details of follow-up testing.
What is Hockenberry’s health status now?
The source does not specify his current condition, whether he remains hospitalized, whether the lymphoma is in remission, or whether further treatment is planned.
Source: furbo.org
